China Healthwise Holdings Limited provided unaudited consolidated group earnings guidance for the half year of 2022. For the period, the group expects to record a loss attributable to owners of the Company within a range of approximately HKD 15 million to approximately HKD 23 million, as compared to a profit attributable to owners of the Company of HKD 37 million for the half year of 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.141 HKD | -4.73% | +76.25% | +243.90% |
03-26 | China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | China Healthwise to Widen Losses in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
+243.90% | 14.59M | |
+20.94% | 72.16B | |
-1.26% | 23.88B | |
+8.25% | 8.35B | |
+5.13% | 8.29B | |
-19.42% | 8.18B | |
+5.56% | 4.81B | |
+16.83% | 4.4B | |
-1.83% | 4B | |
-1.65% | 3.92B |
- Stock Market
- Equities
- 348 Stock
- News China Healthwise Holdings Limited
- China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022